학술논문
Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process
Document Type
article
Author
Blandine Courbiere; Enora Le Roux; Emmanuelle Mathieu d’Argent; Antoine Torre; Catherine Patrat; Christophe Poncelet; Jacques Montagut; Anne-Sophie Gremeau; Hélène Creux; Maëliss Peigné; Isabella Chanavaz-Lacheray; Lara Dirian; Xavier Fritel; Jean-Luc Pouly; Arnaud Fauconnier; on behalf of the PreFerBe Expert Panel
Source
Journal of Clinical Medicine, Vol 10, Iss 17, p 3810 (2021)
Subject
Language
English
ISSN
2077-0383
Abstract
International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification—in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.